|
|
Blood, 1 June 2007, Vol. 109, No. 11, pp. 4724-4731.
Prepublished online as a Blood First Edition Paper on February 20, 2007; DOI 10.1182/blood-2006-08-040006.
Previous Article | Next Article 
Submitted August 7, 2006
Accepted January 26, 2007
Strong iron demand during hypoxia-induced erythropoiesis
is associated with down-regulation of iron-related
proteins and myoglobin in human skeletal muscle
Paul Robach, Gaetano Cairo*, Cecilia Gelfi, Francesca Bernuzzi, Henriette Pilegaard, Agnese Vigano, Paolo Santambrogio, Paolo Cerretelli, Jose A. L. Calbet, Stephane Moutereau, and Carsten Lundby
Departement medical, Ecole Nationale de Ski et d'Alpinisme, Chamonix, France
Institute of General Pathology, University of Milano, Milano, Italy
Department of Sciences and Biomedical Technologies, University of Milano, Segrate, Italy
Copenhagen Muscle Research Centre and Centre of Inflammation, Metabolism, Institute of Molecular Biology & Physiology, University of Copenhagen, Copenhagen, Denmark
Protein Engineering Unit, Dibit, IRCCS H.S. Raffaele, Milano, Italy
Department of Physical Education, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
Laboratoire de Biochimie, Hopital Henri-Mondor, Creteil, France
Department of Sport Science, University of Arhus, Arhus, Denmark
* Corresponding author; email: gaetano.cairo{at}unimi.it.
Iron is essential for oxygen transport because it is incorporated in the heme of oxygen-binding proteins hemoglobin and myoglobin. An interaction between iron homeostasis and oxygen regulation is further suggested during hypoxia, where hemoglobin and myoglobin syntheses have been reported to increase. This study gives new insights into the changes in iron content and iron-oxygen interactions during enhanced erythropoiesis by simultaneously analyzing blood and muscle samples in humans exposed to 7-9 days of high altitude (HA) hypoxia. HA up-regulates iron acquisition by erythroid cells, mobilizes body iron and increases hemoglobin concentration. However, contrary to our hypothesis that muscle iron proteins and myoglobin would also be up-regulated during HA, this study shows that HA lowers myoglobin expression by 35% and down-regulates iron-related proteins in skeletal muscle, as evidenced by decreases in L-ferritin (43%), transferrin receptor (TfR) (50%), and total iron content (37%). This parallel decrease in L-ferritin and TfR in HA occurs independently of increased HIF-1 mRNA levels and unchanged binding activity of iron regulatory proteins, but concurrently with increased ferroportin mRNA levels, suggesting enhanced iron export. Thus, in HA, the elevated iron requirement associated with enhanced erythropoiesis presumably elicits iron mobilization and myoglobin down-modulation, suggesting an altered muscle oxygen homeostasis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Trading muscle iron for erythropoiesis at high altitude
- Chaim Hershko
Blood 2007 109: 4597.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Bekedam, B. J. van Beek-Harmsen, W. van Mechelen, A. Boonstra, and W. J. van der Laarse
Myoglobin concentration in skeletal muscle fibers of chronic heart failure patients
J Appl Physiol,
October 1, 2009;
107(4):
1138 - 1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. I. Wust, R. T. Jaspers, A. F. van Heijst, M. T. E. Hopman, L. J. C. Hoofd, W. J. van der Laarse, and H. Degens
Region-specific adaptations in determinants of rat skeletal muscle oxygenation to chronic hypoxia
Am J Physiol Heart Circ Physiol,
July 1, 2009;
297(1):
H364 - H374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kerenyi and E. W. Mullner
Muscle iron in stress erythropoiesis?
Blood,
June 25, 2009;
113(26):
6507 - 6508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Robach, S. Recalcati, D. Girelli, C. Gelfi, N. J. Aachmann-Andersen, J. J. Thomsen, A. M. Norgaard, A. Alberghini, N. Campostrini, A. Castagna, et al.
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin
Blood,
June 25, 2009;
113(26):
6707 - 6715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lundby, Y. Hellsten, M. B. F. Jensen, A. S. Munch, and H. Pilegaard
Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle
J Appl Physiol,
April 1, 2008;
104(4):
1154 - 1160.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|